ibrutinib,obinutuzumab,venetoclax
roche,abbvie
['leukemia', 'leusm', 'a041702', 'nct03737981', 'cll']
results of a phase 3 study of ivo vs io for previously untreated older pts w/ chronic lymphocytic leukemia (cll) &amp; impact of #covid19 ( a041702) - woyach et al. #asco23 absract 7500 #nct03737981 #cllsm #leusm #geriheme #covid19ncancer
Views my own. VP Clinical Partnerships @TempusLabs #PrecisionMedicine #mmsm #lymsm @ASCO BOD (19-23) #CCC19 @COVID19nCCC https://t.co/ckNS2CepBH